Skip to main content
. 2022 Mar 21;10(3):e003883. doi: 10.1136/jitc-2021-003883

Figure 5.

Figure 5

Differences in tertiary lymphoid structure (TLS) status between kidney and bladder cancer. (A) Differences in TLS maturity between clear cell renal cell carcinoma (ccRCC) (cohort A) and bladder cancer (cohort D). The p value was obtained from the chi-square test. (B) Differences in TLS distribution between ccRCC (cohort A) and bladder cancer (cohort D). The p value was obtained from the χ2 test. (C) Comparison of the tumor area occupied by the TLSs in ccRCC (cohort A) and bladder cancer (cohort D). The p value was obtained from the Mann-Whitney U test. (D) Differences in TLS status according to the infiltration of CD8+/FOXP3+/PD-1+/PD-L1+ cells in ccRCC (cohort A) and bladder cancer (cohort D). The p value was obtained from the χ2 test. (E) summary of TLS status in all tumors of the ccRCC cohort (cohort a) and bladder cancer cohort (cohort D).